In the present study, our findings demonstrated that the level of plasma DEL-1 in stable COPD patients was lower than that in non-COPD patients, with a low baseline DEL-1 level associated with a higher risk of subsequent acute exacerbation in the latter period in patients with COPD. This evidence concerns the gene EDIL3 and chronic obstructive pulmonary disease.